Drug interactions
Palifermin + Sorafenib
Severity: Minor
Palifermin and Sorafenib: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Palifermin is a keratinocyte growth factor used to reduce mucositis from cytotoxic chemotherapy. Its safety and benefit with an oral kinase inhibitor such as sorafenib are not established, and the mucositis concern in labeling applies to cytotoxic chemotherapy.
What this interaction means in plain words
Palifermin and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Palifermin belongs to Miscellaneous; Sorafenib belongs to Oncology.
Why it happens
No established pharmacokinetic mechanism; theoretical concern about stimulating epithelial or tumor cell growth.
What to do
Palifermin is not usually indicated with sorafenib; reserve it for approved myelotoxic regimens. Monitor mucosal toxicity if both are used.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Palifermin and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Sorafenib
Other interactions of Palifermin
Frequently asked questions
Can I take Palifermin with Sorafenib?
MediHelp rates the interaction as minor. Palifermin and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Palifermin is a keratinocyte growth factor used to reduce mucositis from cytotoxic chemotherapy. Its safety and benefit with an oral kinase inhibitor such as sorafenib are not established, and the mucositis concern in labeling applies to cytotoxic chemotherapy.
How serious is the interaction between Palifermin and Sorafenib?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Palifermin is not usually indicated with sorafenib; reserve it for approved myelotoxic regimens. Monitor mucosal toxicity if both are used.
What other medicines interact with Sorafenib?
MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
